Final Programme - iuphar

FC01 Clinical pharmacology in the emerging countries
Mon 001 Patterns of influenza infection in Sylhet division of Bangladesh
Salim Ahmed, (Bangladesh), ATMA Jalil, SS Ahmed, MM Siddika
Mon 002 Comparative study of initial and aquired drug resistance in pulmonary tuberculosis
Seyed Yousef Agha Alaie, (Iran), SD Mansoori, S Khazali, AA Hashtroodi, S Arami
Mon 003 Adverse events of benznidazole in children with Chagas disease – a cohort study
Jaime Altcheh, (Canada), G Moscatelli, S Moroni, F Garcia-Bournissen, H Freilij
Mon 004 Antioxidant activity of phenolic extracts of Tunisian plants and their effect on mitochondrial respiration
in vitro
S Bacha, H Ferchichi, I Salouage, L Ouanes, M Boussaïd, M Lakhal, Anis Klouz, (Tunisia)
Mon 005 Efficacy and safety of add-on mirtazapine in depression
Dinesh K Badyal, (India), P Matreja, R Deswal
Mon 006 Glutathione S-transferase M1 and Glutathione S-transferase T1 polymorphisms and lung cancer risk in
Tunisian men
Majda-Noura Belkhiria, (Tunisia), MA Jebali, I Harrabi, J Knani
Mon 007 Piroxicam provides adequate analgesia after impacted lower third molar removal regardless of the
surgeon’s experience
Adriana Calvo, (Brazil), T Dionísio, F Giglio, P Gonçalves, C Santos
Mon 008 Investigation of the relationship between plasma L-carnitine concentration and its antioxidant activity
after single oral administration of L-carnitine in healthy volunteers
Yu Cao, (PR China), Z-W Han, HJ Qu, C-B Wang
Mon 009 Oral pharmacokinetics of three fluoroquinolones in Mexicans: Evidence for interethnic differences
Miriam Carrasco-Portugal, (Mexico), G Lozoya-Moreno, S Patiño-Camacho, F Flores-Murrieta
Mon 010 Patient’s access to antiretroviral medicines: how do they view themselves?
DM Carvalho, MH Magalhães, AMR Felix, ECA Costa, WA Souza, Marcia HMC Podestá, (Brazil)
Mon 011 Inequivalence of doxorubicin liposomal formulations commercialized in Latin America
Gilberto Castañeda-Hernández, (Mexico), L Villafaña-Godínez, MA Valdés, L González-Flores
Mon 012 In vitro antiplasmodial activity of 8-hydroxyquinoline derivatives
Chien-Teng Chen, (South Africa), R van Zyl
Mon 013 Association of the ABCB1 3435C>T polymorphism and adverse events of cilostazole in healthy
subjects
Sung Kweon Cho, (South Korea), LA Lim, SB Jang, YJ Lee, DH Lee, HK Son, JY Chung, K Park
Mon 014 Pharmapoly, game as a teaching strategy in pharmacology classes
Luis Cifuentes, (Colombia)
Mon 015 Summary of PK and PD in a practical way
Luis Cifuentes, (Colombia),
Mon 016 Pharmacokinetics of florfenicol (water soluble formulation) in health and Pasteurella infected broiler
chickens
Hesham Elzorba, (Egypt), H El-Banna
Mon 017 Antibiotic activity against urinary pathogens in hospitalized medical patients in eastern Nigeria
Oguamanam Enwere, (Nigeria), K Duruewuru, V Okwara
160 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area